Eli Lilly and Company (LLY)
853.00 x 1 863.35 x 1
Pre-market by (Cboe BZX)
852.35 -12.55 (-1.45%) 03/25/25 [NYSE]
853.00 x 1 863.35 x 1
Pre-market 855.31 +2.96 (+0.35%) 19:00 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 13,532,800 | 11,439,100 | 11,302,800 | 8,768,000 | 9,353,402 |
| Cost of Goods | 2,403,800 | 2,170,800 | 2,170,200 | 1,673,500 | 1,788,000 |
| Gross Profit | 11,129,000 | 9,268,300 | 9,132,600 | 7,094,500 | 7,565,402 |
| Operating Expenses | 9,242,400 | 4,916,300 | 4,983,000 | 4,586,000 | 8,152,701 |
| Operating Income | 1,887,403 | 4,352,799 | 4,149,800 | 2,509,000 | -587,299 |
| Other Income | 3,151,297 | -2,764,399 | -632,600 | 27,100 | 3,096,099 |
| Pre-tax Income | 5,038,700 | 1,588,400 | 3,517,200 | 2,536,100 | 2,508,800 |
| Income Tax | 628,900 | 618,100 | 550,200 | 293,200 | 319,100 |
| Net Income Continuous | 4,409,800 | 970,300 | 2,967,000 | 2,242,900 | 2,189,700 |
| Net Income | $4,409,800 | $970,300 | $2,967,000 | $2,242,900 | $2,189,700 |
| EPS Basic Total Ops | 4.90 | 1.08 | 3.29 | 2.49 | 2.43 |
| EPS Basic Continuous Ops | 4.90 | 1.08 | 3.29 | 2.49 | 2.43 |
| EPS Diluted Total Ops | 4.88 | 1.07 | 3.28 | 2.48 | 2.42 |
| EPS Diluted Continuous Ops | 4.88 | 1.07 | 3.28 | 2.48 | 2.42 |
| EPS Diluted Before Non-Recurring Items | 5.32 | 1.18 | 3.92 | 2.58 | 2.49 |
| EBITDA(a) | $2,372,204 | $4,819,600 | $4,564,200 | $2,909,600 | $-199,599 |